Eurofins Scientific SE (ERFSF)
ERFSF Stock Price Chart
Explore Eurofins Scientific SE interactive price chart. Choose custom timeframes to analyze ERFSF price movements and trends.
ERFSF Company Profile
Discover essential business fundamentals and corporate details for Eurofins Scientific SE (ERFSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
26 Apr 2010
Employees
62.70K
Website
https://www.eurofins.comCEO
Gilles G. Martin
Description
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
ERFSF Financial Timeline
Browse a chronological timeline of Eurofins Scientific SE corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Jan 2026
Earnings released on 23 Jul 2025
EPS came in at $1.93 falling short of the estimated $2.01 by -3.98%, while revenue for the quarter reached $3.96B , missing expectations by -7.16%.
Dividend declared on 23 Apr 2025
A dividend of $0.68 per share was announced, adjusted to $0.68. The dividend was paid on 30 Apr 2025.
Earnings released on 30 Jan 2025
EPS came in at $0.99 falling short of the estimated $1.54 by -35.78%, while revenue for the quarter reached $3.66B , beating expectations by +108.09%.
Earnings released on 22 Oct 2024
EPS came in at $1.22 falling short of the estimated $1.59 by -23.27%, while revenue for the quarter reached $3.68B , missing expectations by -1.11%.
Dividend declared on 24 Jun 2024
A dividend of $0.54 per share was announced, adjusted to $0.54. The dividend was paid on 5 Jul 2024.
Earnings released on 24 Apr 2024
EPS came in at $0.88 falling short of the estimated $1.32 by -33.03%, while revenue for the quarter reached $3.63B , missing expectations by -1.41%.
Earnings released on 30 Jun 2023
EPS came in at $0.83 falling short of the estimated $1.38 by -39.57%, while revenue for the quarter reached $3.50B , missing expectations by -0.03%.
Dividend declared on 20 Jun 2023
A dividend of $1.09 per share was announced, adjusted to $1.09. The dividend was paid on 6 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at $1.63 surpassing the estimated $1.59 by +2.52%, while revenue for the quarter reached $3.56B , missing expectations by -1.26%.
Earnings released on 18 Oct 2022
EPS came in at $1.62 falling short of the estimated $2.05 by -20.98%, while revenue for the quarter reached $3.57B , missing expectations by -0.20%.
Earnings released on 21 Apr 2022
EPS came in at $2.08 falling short of the estimated $2.52 by -17.46%, while revenue for the quarter reached $3.91B , beating expectations by +1.08%.
Dividend declared on 22 Feb 2022
A dividend of $1.03 per share was announced, adjusted to $1.04. The dividend was paid on 7 Jul 2022.
Earnings released on 21 Oct 2021
EPS came in at $2.45 falling short of the estimated $2.80 by -12.50%, while revenue for the quarter reached $3.88B , beating expectations by +0.87%.
Earnings released on 28 Apr 2021
EPS came in at $2.77 surpassing the estimated -$5.76 by +148.07%, while revenue for the quarter reached $3.82B , beating expectations by +0.33%.
Dividend declared on 1 Mar 2021
A dividend of $0.81 per share was announced, adjusted to $0.81. The dividend was paid on 5 Jul 2021.
Stock split effective on 19 Nov 2020
Shares were split 10 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 22 Oct 2020
EPS came in at $0.56 falling short of the estimated $0.86 by -35.12%, while revenue for the quarter reached $2.61B , beating expectations by +1.12%.
ERFSF Stock Performance
Access detailed ERFSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.